Reactant involved in the synthesis of biologically active molecules includinglactate dehydrogenase inhibitors for use against cancer cell proliferation.

For R&D use onlynot for drug household or other uses.

B-[4-(Trifluoromethoxy)phenyl]boronic Acid is a reagent used in the synthesis of orally bioavailable matrix metalloprotinase inhibitors. Also used in the preparation of chromen-4-one inhibitors used against DNA dependant protein kinases.